1. Home
  2. CDRE vs IOVA Comparison

CDRE vs IOVA Comparison

Compare CDRE & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDRE
  • IOVA
  • Stock Information
  • Founded
  • CDRE 2012
  • IOVA 2007
  • Country
  • CDRE United States
  • IOVA United States
  • Employees
  • CDRE N/A
  • IOVA N/A
  • Industry
  • CDRE Industrial Specialties
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CDRE Health Care
  • IOVA Health Care
  • Exchange
  • CDRE Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • CDRE 1.2B
  • IOVA 771.4M
  • IPO Year
  • CDRE 2021
  • IOVA N/A
  • Fundamental
  • Price
  • CDRE $32.23
  • IOVA $1.74
  • Analyst Decision
  • CDRE Buy
  • IOVA Buy
  • Analyst Count
  • CDRE 2
  • IOVA 10
  • Target Price
  • CDRE $37.50
  • IOVA $12.22
  • AVG Volume (30 Days)
  • CDRE 297.7K
  • IOVA 11.7M
  • Earning Date
  • CDRE 08-08-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • CDRE 1.18%
  • IOVA N/A
  • EPS Growth
  • CDRE N/A
  • IOVA N/A
  • EPS
  • CDRE 0.95
  • IOVA N/A
  • Revenue
  • CDRE $559,807,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • CDRE $13.31
  • IOVA $86.62
  • Revenue Next Year
  • CDRE $7.96
  • IOVA $69.95
  • P/E Ratio
  • CDRE $34.04
  • IOVA N/A
  • Revenue Growth
  • CDRE 10.06
  • IOVA 11070.12
  • 52 Week Low
  • CDRE $27.07
  • IOVA $1.64
  • 52 Week High
  • CDRE $40.28
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • CDRE 43.48
  • IOVA 38.67
  • Support Level
  • CDRE $31.58
  • IOVA $1.67
  • Resistance Level
  • CDRE $32.36
  • IOVA $1.82
  • Average True Range (ATR)
  • CDRE 0.88
  • IOVA 0.12
  • MACD
  • CDRE -0.23
  • IOVA -0.00
  • Stochastic Oscillator
  • CDRE 19.02
  • IOVA 13.85

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: